Inhaledsteroids in COPD? Not in Mybook!

Inhaledsteroids in COPD? Not in Mybook!

  
Authored by Geertjan Wesseling

Chronic Obstructive Pulmonary Disease COPD, is currently the fourth leading cause of death in the world, but projected to be the 3rd leading cause by 2020. More than 3 million people died of COPD in 2012, accounting for 6% of all deaths worldwide. COPD represents an important public health challenge that is both preventable and treatable, if not curable [1]. Characteristically, bronchitis andemphysema are both present in most patients. Smoking cessation is by far the most effective intervention in COPD resulting in better health status, less exacerbations and improved survival [2]. Physical exercise, especially when in the shape of multidisciplinary rehabilitation also has significant effects [3].

To view more Full Text in Juniper Publishers

Comments

Post a Comment

Popular posts from this blog

Juniper Publishers 2025 Journal Categories Explained: Medicine, Biology, Engineering & More Introduction

  In 2025, multidisciplinary research continues to grow, making journal selection more important than ever. Juniper Publishers is a multidisciplinary open-access publisher offering a broad portfolio of peer-reviewed journals across medicine, life sciences, engineering, physical sciences, social sciences, and emerging interdisciplinary fields. With its expanding journal ecosystem, Juniper Publishers provides researchers, clinicians, and academicians with targeted platforms to publish scholarly work aligned with specific disciplines. This guide explains the major journal categories at Juniper Publishers , helping authors identify suitable publication outlets for their research. For an overview of the publisher’s mission, scope, and structure, authors can refer to the official profile here: 👉 https://juniperpublishers.com/aboutus.php 1. Medical & Clinical Sciences Medical and clinical journals form a core part of the Juniper Publishers portfolio. These journals a...
Read more

Application of a Real-Time Dashboard to Reduce Ventilator-Associated Pneumonia in Intensive Care Units

Image
Application of a Real-Time Dashboard to Reduce Ventilator-Associated Pneumonia in Intensive Care Units Authored by Mohammad Fathi Ventilator-associated pneumonia is the second most common nosocomial infection that develops in patients admitted to the intensive care unit. The mortality rate for VAP ranges from 24% to 76% and is even higher than the primary illness. Based on the importance of this issue, many organizations have focused on strategies and guidelines to reduce the occurrence of complications such as ventilator associated pneumonia. Despite these guidelines, due to multi orders with different conditions and time periods, multi caregivers in the intensive care unit and human mistakes, still there are high rates of VAP. The purpose of this study is to provide an overview of real-time dashboards applications which were designed and implemented as a solution to reduce Ventilator-associated-pneumonia in Intensive Care Unit. To view more Full Text in J...
Read more

Deadly High Altitude Pulmonary Disorders: Acute Mountain Sickness (AMS); High Altitude Pulmonary Edema (HAPE) and High Altitude Cerebral Edema (HACE): A Clinical Review

Image
Deadly High Altitude Pulmonary Disorders: Acute Mountain Sickness (AMS); High Altitude Pulmonary Edema (HAPE) and High Altitude Cerebral Edema (HACE): A Clinical Review Authored by  Michael Obrowski Mountain Sickness, also called High Altitude Sickness, is specifically a triad of different disorders, in order of increasing seriousness: Acute Mountain Sickness (AMS); High Altitude Pulmonary Edema (HAPE) and High Altitude Cerebral Edema (HACE). These three disorders, with relatively unimportant small variations seen in some Pulmonology Textbooks, because these are so serious, they are all potentially deadly pulmonary disorders and we will discuss these three major, deadly disorders. Each one, starting with AMS, can progress rapidly to HAPE and then HACE.  To view more FullText in JuniperPublishers
Read more